EVO 3.22 (+4.55%)
US30050E1055Drug ManufacturersDrug Manufacturers - Specialty & Generic

Evotec (EVO) Stock Highlights

3.22 | +4.55%
2024-10-21 02:44:18
Evotec SE is a drug discovery partnership company providing solutions to pharmaceutical & biotechnology companies, academic institutions as well as foundations, and not-for-profit organizations. The company offers its services in the area of neuronal diseases, diabetes & its complications, pain, inflammation, oncology, infectious diseases, respiratory & fibrosis, rare disease, and womens health. Its business segments are EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone drug discovery services on a typical fee-for-service basis or integrated drug discovery collaborations. The EVT Innovate segment develops drug discovery programs and assets, both internally or through academic collaborations. The majority of its revenue is derived from the EVT Execute segment.

Statistics

Range Today
3.17 3.23
Volume Today 94.9K
Range 1 Year
2.85 12
Volume 1 Year 22.94M
Range 3 Year
2.85 26.57
Volume 3 Year 53.93M
Range 10 Year
1.5675 106.1
Volume 10 Year 62.98M

Highlights

Market Capitalization 1.14B (small)
Floating Shares 146.7M
Current Price 3.22
Price To Earnings -6.15
Price To Revenue 0.95
Price To Book 0.56
Earnings Per Share -0.52
Payout Ratio 0%

Performance

Latest +4.55%
1 Month -11.54%
3 Months -34.42%
6 Months -54.26%
1 Year -64.5%
3 Years -86.81%
5 Years -70.23%
10 Years +91.67%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.